CATX vs CF · rev $2.2M vs P/E 12, rev $5.94B
Perspective Therapeutics Inc. (CATX) versus CF Industries Holdings Inc (CF) — a side-by-side from cached financials, not a winner call.
Perspective Therapeutics Inc. (CATX) is a medical devices company listed on US.
CF Industries Holdings Inc (CF) is a agricultural inputs company listed on US.
Latest reported CATX revenue for 2023-09-30 was $2.2M. Net income was -$10.4M. Revenue was up 4.6% from 2023-06-30 to 2023-09-30. CATX currently screens at market cap $280.6M.
Latest reported CF revenue for 2024-12-31 was $5.94B. Net income was $1.48B. Revenue was down 10.5% from 2023-12-31 to 2024-12-31. CF currently screens at market cap $14.98B and trailing P/E 12.2.
CATX currently screens at market cap $280.6M. CF currently screens at market cap $14.98B and trailing P/E 12.2.
Not investment advice. Open the CATX and CF stock pages for the full models.
Not investment advice.